Opinion: New Alberta centre will find best practices for mental health, addictions

FOR IMMEDIATE RELEASE June 2, 2026 CALGARY — A new peer-reviewed article published in Pharmaceuticals and co-authored by CoRE’s Chief Scientific Officer, Dr. Nathaniel Day, suggests buprenorphine, a medication commonly used to treat opioid use disorder, may also reduce the risk of fentanyl-induced respiratory depression, the primary cause of fatal opioid overdoses. The paper examines … Continued

FOR IMMEDIATE RELEASEMarch 10, 2026 Calgary, Alberta—Today, Addiction, the globally leading scientific journal, published CORE’s landmark findings on how the closure of an Overdose Prevention Site in Red Deer, Alberta did not result in increased deaths, emergency department visits, or EMS (ambulance) calls for site users and after the site closed, more site users sought … Continued

FOR IMMEDIATE RELEASEJune 4, 2025 Calgary, Alberta—The Canadian Centre of Recovery Excellence (CoRE), in collaboration with Dr. Charl Els, is pleased to announce the publication of a new position paper, Cannabis in Safety-Sensitive Industries.  Endorsed by the Occupational and Environmental Medical Association of Canada (OEMAC), this paper has been published for peer review in the … Continued